Change in Darbepoetin Alfa Administration Schedule Affects Erythropoiesis-Stimulating Agent Resistance in Patients with Chronic Kidney Disease Receiving Hemodialysis

Author: Molina Manuel   Navarro Maria Jose   de Gracia Carmen   Alvarez Gracia   de Alarcon Rosa   Garcia Maria Angeles  

Publisher: Informa Healthcare

ISSN: 0886-022X

Source: Renal Failure, Vol.30, Iss.8, 2008-09, pp. : 778-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content